Penumbra ROE 2014-2025 | PEN
Current and historical return on equity (ROE) values for Penumbra (PEN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Penumbra ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.15B | $1.29B | 12.43% |
| 2025-03-31 | $0.04B | $1.21B | 3.72% |
| 2024-12-31 | $0.02B | $1.15B | 1.30% |
| 2024-09-30 | $0.04B | $1.10B | 3.01% |
| 2024-06-30 | $0.01B | $1.16B | 1.20% |
| 2024-03-31 | $0.09B | $1.20B | 8.17% |
| 2023-12-31 | $0.09B | $1.18B | 8.32% |
| 2023-09-30 | $0.04B | $1.10B | 3.91% |
| 2023-06-30 | $0.03B | $1.07B | 2.95% |
| 2023-03-31 | $0.01B | $1.02B | 0.71% |
| 2022-12-31 | $0.00B | $1.00B | -0.21% |
| 2022-09-30 | $-0.03B | $0.97B | -3.21% |
| 2022-06-30 | $-0.02B | $0.97B | -2.24% |
| 2022-03-31 | $-0.01B | $0.96B | -0.86% |
| 2021-12-31 | $0.00B | $0.95B | 0.68% |
| 2021-09-30 | $0.03B | $0.69B | 5.14% |
| 2021-06-30 | $0.02B | $0.67B | 2.48% |
| 2021-03-31 | $0.00B | $0.65B | -0.79% |
| 2020-12-31 | $-0.02B | $0.64B | -2.70% |
| 2020-09-30 | $-0.01B | $0.62B | -1.80% |
| 2020-06-30 | $0.01B | $0.62B | 1.94% |
| 2020-03-31 | $0.04B | $0.49B | 8.23% |
| 2019-12-31 | $0.05B | $0.49B | 10.63% |
| 2019-09-30 | $0.05B | $0.47B | 10.34% |
| 2019-06-30 | $0.02B | $0.45B | 3.72% |
| 2019-03-31 | $0.01B | $0.44B | 2.84% |
| 2018-12-31 | $0.01B | $0.42B | 1.44% |
| 2018-09-30 | $0.01B | $0.41B | 1.94% |
| 2018-06-30 | $0.03B | $0.43B | 6.65% |
| 2018-03-31 | $0.01B | $0.42B | 3.05% |
| 2017-12-31 | $0.00B | $0.40B | 1.05% |
| 2017-09-30 | $-0.01B | $0.38B | -2.00% |
| 2017-06-30 | $0.01B | $0.37B | 1.58% |
| 2017-03-31 | $0.01B | $0.37B | 3.50% |
| 2016-12-31 | $0.02B | $0.27B | 5.96% |
| 2016-09-30 | $0.02B | $0.25B | 7.40% |
| 2016-06-30 | $0.01B | $0.25B | 2.53% |
| 2016-03-31 | $0.00B | $0.24B | 1.14% |
| 2015-12-31 | $0.00B | $0.23B | 0.87% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.968B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.84 |
| Intuitive Surgical (ISRG) | United States | $196.987B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.662B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.588B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.25 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |